Holdings

Royalty Pharma Sub-Manager, LLC

As of Sep 30, 2026, Royalty Pharma Sub-Manager, LLC reported 4 positions worth US$196M. Largest: Cytokinetics, Incorporated, Zenas BioPharma, Inc. and Biohaven Ltd. What it bought and sold, with each filing.

CompanySharesValue as reportedChangeAs of
Cytokinetics, Incorporated980KUS$64.6Mno changeSep 30, 2026
Zenas BioPharma, Inc.2.39MUS$64.4Mno changeSep 30, 2026
Biohaven Ltd.2.94MUS$39.2Mno changeSep 30, 2026
Kailera Therapeutics, Inc.2.46MUS$28Mno changeSep 30, 2026